The National Academies Logo
Research Associateship Programs
Fellowships Office
Policy and Global Affairs

Participating Agencies - AMRMC

  Sign InPrintable View

Opportunity at U.S. Army Medical Research & Materiel Command (AMRMC)

Development of Vaccines and Therapeutics to Hemorrhagic Fever Viruses


U.S. Army Medical Research Institute of Infectious Diseases, US Army Medical Research Insti Infec Diseases

RO# Location
97.20.00.B7513 Fort Detrick, MD 217025011


Name E-mail Phone
Dye, John Michael 301.619.8782


Opportunities are available for basic or applied research on emerging viral diseases with a particular emphasis on viruses causing hemorrhagic fever including Ebola virus and Marburg virus. The laboratory focuses on two fronts: filovirus vaccines and therapeutics. Current efforts focus on the development of filovirus vaccines (VLP and VRP) in NHP models and assessing the importance of immune interference generated by different vaccine candidates, evaluation of the potency of a vascular permeability inhibitor as a broad spectrum therapeutic, and generation of the only SEBOV specific monoclonal antibodies (patent) currently available for use. Lastly, the laboratory is on the forefront of research addressing the use of antibodies as a therapeutic for filovirus infection.



Dye, JM, et al: Proceedings of the National Academy of Sciences: December, 2011 (epub)

Carette JE, et al: Nature 477: 7364, 2011

Bradfute SB, Dye JM, Bavari S: Human Vaccines (7)6: 1, 2011


Filovirus; Ebola; Marburg; Vaccine; Therapeutic; Immunology; Antibody; Hemorrhagic;


Citizenship:  Open to U.S. citizens
Level:  Open to Postdoctoral and Senior applicants
Copyright © 2014. National Academy of Sciences. All rights reserved. 500 Fifth St. N.W., Washington, D.C. 20001.
Terms of Use and Privacy Statement.